Sharps Technology, Inc. (STSS)
USD 4.75
(-9.35%)
USD 4.75
(-9.35%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.78 Million USD | -0.43% |
| 2022 | 11.83 Million USD | 100.59% |
| 2021 | 5.9 Million USD | 164.43% |
| 2020 | 2.23 Million USD | 237.47% |
| 2019 | 661.4 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 9.8 Million USD | -16.84% |
| 2024 Q2 | 9.93 Million USD | 1.31% |
| 2023 Q4 | 11.78 Million USD | -17.97% |
| 2023 Q2 | 11.79 Million USD | -12.84% |
| 2023 FY | 11.78 Million USD | -0.43% |
| 2023 Q1 | 13.53 Million USD | 14.29% |
| 2023 Q3 | 14.37 Million USD | 21.85% |
| 2022 Q3 | 13.53 Million USD | -9.94% |
| 2022 FY | 11.83 Million USD | 100.59% |
| 2022 Q2 | 15.02 Million USD | 204.46% |
| 2022 Q1 | 4.93 Million USD | -16.38% |
| 2022 Q4 | 11.83 Million USD | -12.51% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q3 | 3.75 Million USD | 26.22% |
| 2021 Q4 | 5.9 Million USD | 57.12% |
| 2021 FY | 5.9 Million USD | 164.43% |
| 2021 Q2 | 2.97 Million USD | 0.0% |
| 2020 Q4 | 2.23 Million USD | 0.0% |
| 2020 FY | 2.23 Million USD | 237.47% |
| 2019 FY | 661.4 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 93.464% |
| AngioDynamics, Inc. | 317.67 Million USD | 96.289% |
| AtriCure, Inc. | 613.93 Million USD | 98.08% |
| Avinger, Inc. | 13.77 Million USD | 14.384% |
| Azenta, Inc. | 2.88 Billion USD | 99.591% |
| BioLife Solutions, Inc. | 412.71 Million USD | 97.143% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.899% |
| Daxor Corporation | 34.86 Million USD | 66.19% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | 59.232% |
| Femasys Inc. | 27.75 Million USD | 57.525% |
| GlucoTrack, Inc. | 4.9 Million USD | -140.352% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 91.418% |
| Hologic, Inc. | 9.15 Billion USD | 99.871% |
| ICU Medical, Inc. | 4.37 Billion USD | 99.731% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.924% |
| KORU Medical Systems, Inc. | 28.46 Million USD | 58.577% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 96.6% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -89.576% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -89.576% |
| Masimo Corporation | 3.04 Billion USD | 99.612% |
| Microbot Medical Inc. | 8.32 Million USD | -41.579% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 93.142% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 99.493% |
| Nephros, Inc. | 11.86 Million USD | 0.605% |
| NovoCure Limited | 1.14 Billion USD | 98.971% |
| NEXGEL, Inc. | 9.95 Million USD | -18.426% |
| NEXGEL, Inc. | 9.95 Million USD | -18.426% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 95.559% |
| OraSure Technologies, Inc. | 482.84 Million USD | 97.558% |
| Pro-Dex, Inc. | 54.21 Million USD | 78.253% |
| Pulse Biosciences, Inc. | 60.8 Million USD | 80.611% |
| Predictive Oncology Inc. | 14.41 Million USD | 18.228% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | 30.293% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.862% |
| Repligen Corporation | 2.82 Billion USD | 99.583% |
| Sanara MedTech Inc. | 73.87 Million USD | 84.041% |
| STAAR Surgical Company | 488.69 Million USD | 97.588% |
| Utah Medical Products, Inc. | 135.45 Million USD | 91.297% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.84% |
| Jin Medical International Ltd. | 32.9 Million USD | 64.17% |